P1713: VENETOCLAX IN COMBINATION WITH OBINUTUZUMAB IN FIRST LINE CHRONIC LYMPHOCYTIC LEUKEMIA IN ARGENTINA: A COST-EFFECTIVENESS ANALYSIS

por Kanevsky, D., Elgart, J., Zerga, M., Glancszpigel, M., Morisset, P.
Publicado 2022

PB1865: SINGLE-COUNTRY, MULTICENTER, RETROSPECTIVE, OBSERVATIONAL, DESCRIPTIVE COHORT STUDY OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH VENETOCLAX IN ARGENTINA (VENARG).

por Pagano Vilar, C., Pavlovsky, M. A., Tannuri, R. K., Enrico Mattos, A., Zerga, M., Guanchiale, L., Custidiano, R., Miroli, A., Higashigata, M., Figueroa, F., Pose Cabarcos, J., Real, J., Giordano, L., Miodosky, M., De Stefano, G., Federico, A., Klimovsky, E., Cugliari, M. S.
Publicado 2022